U.S. Markets closed

Halozyme Therapeutics, Inc. (HALO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
12.4100-0.19 (-1.51%)
At close: 4:00PM EDT
People also watch
Currency in USD

Valuation Measures

Market Cap (intraday) 51.72B
Enterprise Value 3N/A
Trailing P/E -13.70
Forward P/E 1-15.32
PEG Ratio (5 yr expected) 1-0.23
Price/Sales (ttm)12.85
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Mar 31, 2017
Profit Margin -86.80%
Operating Margin (ttm)-70.70%
Management Effectiveness
Return on Assets (ttm)-22.06%
Return on Equity (ttm)N/A
Income Statement
Revenue (ttm)133.76M
Revenue Per Share (ttm)1.04
Quarterly Revenue Growth (yoy)-30.40%
Gross Profit (ttm)113.48M
EBITDA -92.04M
Net Income Avi to Common (ttm)-116.1M
Diluted EPS (ttm)-0.91
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)178.99M
Total Cash Per Share (mrq)1.39
Total Debt (mrq)214.03M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.60
Book Value Per Share (mrq)-0.46
Cash Flow Statement
Operating Cash Flow (ttm)-59.82M
Levered Free Cash Flow (ttm)-34.77M

Trading Information

Stock Price History
Beta 2.59
52-Week Change 325.25%
S&P500 52-Week Change 315.17%
52 Week High 315.2000
52 Week Low 37.7000
50-Day Moving Average 313.4474
200-Day Moving Average 312.5825
Share Statistics
Avg Vol (3 month) 31.28M
Avg Vol (10 day) 31.9M
Shares Outstanding 5138.52M
Float 108.27M
% Held by Insiders 13.68%
% Held by Institutions 177.40%
Shares Short 325.24M
Short Ratio 318.3
Short % of Float 326.53%
Shares Short (prior month) 325.3M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A